Quick Takeaways
- Nantahala Capital Management, LLC filed SCHEDULE 13G/A for ZEVRA THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (ZVRA).
- Disclosed ownership: 4.4%.
- Date of event: 31 Dec 2024.
Quoteable Key Fact
"Nantahala Capital Management, LLC disclosed 4.4% ownership in ZEVRA THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (ZVRA) on 31 Dec 2024."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 4.4% | 2,340,333 | 0 | 2,340,333 | /s/ Taki Vasilakis | Taki Vasilakis / Chief Compliance Officer | |
| Wilmot B. Harkey | 4.4% | 2,340,333 | 0 | 2,340,333 | /s/ Wilmot B. Harkey | Wilmot B. Harkey | |
| Daniel Mack | 4.4% | 2,340,333 | 0 | 2,340,333 | /s/ Daniel Mack | Daniel Mack |